The natural history of congenital or childhood non-immune, isolated atrioventricular (AV) block is poorly defined.
Introduction
Congenital atrioventricular (AV) block is a rare disorder, associated with a risk of sudden death in the absence of cardiac pacing. The estimated prevalence of isolated AV block in structurally normal hearts is 1 per 15 000 -20 000 live births. 1, 2 Autoimmune disease in the mother is the cause of 90 -99% of all cases diagnosed before 6 months of age, due to the transplacental passage of maternal anti-Ro/SSA and/or anti-La/SSB autoantibodies that enter the foetal circulation, trigger an inflammatory response and irreversible fibrosis of the cardiac conduction system, and downregulate cardiac L-type Calcium channels. 3 -5 Very rarely, AV block of unknown origin appears during childhood, in the absence of maternal antibodies, structural heart disease, or other overt causes, such as trauma, metabolic abnormalities, or infection. 6 While the characteristics of foetal and maternal antibody-associated AV block have been largely clarified, the clinical course of isolated, non-immune AV block diagnosed in utero, at birth, or during childhood remains obscure. This retrospective multicentre study examined the natural history and longterm outcomes associated with this form of AV block.
Methods Definitions
Atrioventricular block was classified as congenital if it was diagnosed in utero, at birth, or during the first month of life, vs. childhood AV block, if diagnosed between the 1st month and the 15th year of life. 7 Atrioventricular and intraventricular conduction disturbances were classified according to the age at the time of diagnosis using the definitions of recent international practice guidelines. 8 -10 Complete (third degree) AV block was defined as (i) regular RR intervals at a .1000 ms cycle length, (ii) regular PP intervals at a ,1000 ms cycle length, and (iii) irregular PR intervals. Incomplete heart block included first degree AV block and type I or type II second degree AV block. QRS duration was classified according to age. QRS was classified as narrow when ,80 ms in duration before 8 years, and ,90 ms between 8 and 16 years of age. Dilated cardiomyopathy (DCM) was defined as a left ventricular (LV) end-diastolic diameter .97th percentile, associated with a ,25% fractional shortening on two-dimensional transthoracic echocardiogram.
Study design
Children treated between 1980 and 2009 for incomplete or complete AV block at 13 French, tertiary hospitals were retrospectively included in this analysis. Patients born before 1980 were excluded from this study because of the major progress in prenatal diagnosis, neonatal management of AV block, and pacing technology, made during the study period. We also excluded the cases of (i) postoperative heart block; (ii) myocarditis, neuromuscular disorders, metabolic diseases, and congenital heart disease that were probable causes of AV block; (iii) heart block associated with pharmacotherapy that the mother or child were following that may have contributed to the conduction abnormalities; and (iv) patients with positive maternal anti-Ro/SSA and anti-La/SSB antibodies. Since (i) 9% of mothers who are sero-negative at the time of foetal diagnosis later become seropositive, 11 and (ii) once they are detected, the antibodies remain permanently in the maternal serum, 12, 13 the mothers of all patients included in this study systematically underwent at the time of inclusion, a screening for antibodies to soluble nuclear antigens 48 kDa SSB/La, 52 kDa SSA/Ro, and 60 kDa SSA/Ro, using previously described high-sensitivity, quantitative radioligand assays. 14 The earliest documentation of a patient's conduction abnormality was used as the time of diagnosis of AV block. Children were included if presenting an isolated, non-immune AV block diagnosed in utero, or up to 15 years of age. The patients were identified using the diagnostic database of the French hospitals' national coding system. Specific and pertinent clinical data, collected by consulting each patient's medical records, included age at the time of, and symptoms associated with, the diagnosis of the conduction disturbance, type of heart block diagnosed, echocardiographic observations, age and type of heart block at time of first pacemaker implantation when applicable, pacing type and mode of pacing, and clinical status throughout the follow-up.
Standard 12-lead electrocardiograms (ECG) were recorded in all patients at both times of diagnosis and pacemaker implantation, or at last follow-up in non-paced patients. The ECG were analysed by two blinded investigators, and the heart rate, PR (not included in case of complete AV block), QRS, and QT interval durations were measured, using the DatInf w Measure dedicated software (Datinf GmbH, Tübingen, Germany). The QT interval was corrected for heart rate, using Bazett's formula.
The study was reviewed and approved by the appropriate institutional ethics committees, and all patients or legal guardians granted their informed consent to be included in the database.
Follow-up
All children underwent ≥2 ambulatory follow-up visits per year with a paediatric cardiologist, for surveillance of their clinical status, ECG, and echocardiogram. For the specific purpose of this study, data were collected by two investigators (A.E.B. and V.P.), who, at the end of follow-up (i) reviewed the medical records of all participants in the study, and (ii) contacted all patients or legal guardians by telephone, to ascertain the incidence of fatal and non-fatal disease-related adverse events.
Statistical analysis
Relevant variables were expressed either as counts and percentages or as mean value + standard deviation. To assess the variables independency, Chi-square and Fisher's exact tests were performed using the PASWw Statistics 18 software (SPSS Inc., Chicago, IL, USA). A twosided P-value ,0.05 was considered statistically significant.
Results
A total of 177 unrelated children fulfilled the study inclusion criteria. We subsequently excluded 36 patients because of (i) missing echocardiographic data at the time of diagnosis (n ¼ 6), (ii) unknown maternal immune status (n ¼ 13), and (iii) loss of follow-up (n ¼ 17), leaving 141 patients (72 females) in the final analysis.
Age at diagnosis
The mean age at the time of diagnosis was 3.6 + 4.2 years, ranging from in utero to 12 years. Congenital AV block was diagnosed in 26 (18.4%), and childhood AV block in 115 (81.6%) patients ( Figure 1 ). Among patients with congenital AV block, 12 were diagnosed in utero, at a mean gestational age of 36.8 + 2.1 weeks (20 -39), and 14 were diagnosed at birth or in the neonatal period. Childhood AV block was diagnosed during the first year of life in 22 (15.6%), between 1 and 5 years of age in 57 (40.4%), between 5 and 10 years of age in 22 (15.6%), and between 10 and 15 years of age in 14 (9.9%) children. The diagnosis was made before 5 years of age in 105 cases (74.5%).
Clinical presentation at the time of diagnosis
Atrioventricular block was detected by disease manifestations in only 22 children (15.6%), including syncope in 10 (7%), fatigue in 6 (4.3%), and heart failure in 6 (4.3%), 4 of whom were neonates. Atrioventricular block was asymptomatic in 119 patients (84.4%), and was diagnosed after the detection of bradycardia in 72 (51.0%), heart murmur in 24 (17.0%), or both in 22 (15.7%) patients. In one asymptomatic child who had a family history of AV block, the diagnosis was made by screening.
Conduction disturbances at the time of diagnosis
Complete AV block was present on the ECG of 100 patients (70.9%), including 18 children with congenital (69.2%) and 82 with childhood (71.3%) AV block ( Figure 2) . In four patients, paroxysmal, complete AV block progressed to permanent, complete AV block within a mean of 38.2 + 44.9 months (1-102). Incomplete AV block was diagnosed in 41 patients (29.1%), including 8 patients with congenital (30.7%) and 33 patients with childhood (28.7%) AV block, ranging from first degree AV block in 4 (2.8%), to type I second degree AV block in 10 (7.1%), to type II second degree AV block in 27 patients (19.2%). Incomplete (first or second degree) AV block progressed to permanent, complete AV block within a mean of 2.8 + 3.4 years (1-155 months) in 29 of 41 (70.7%) patients ( Figure 3 ), but all patients with incomplete AV block may not have been included in the study.
Three of the four children with first degree AV block (mean PR duration: 236.5 + 40.7 ms, from 210 to 296 ms) also had intraventricular conduction disturbances with two complete right bundle branch block (RBBB) and one complete left bundle branch block (LBBB). The fourth one had narrow QRS complex. The one presenting with complete LBBB was congenital, diagnosed at the fifth day of life, because of bradycardia, and rapidly progressed to complete AV block, leading to neonatal permanent pacemaker implantation. The three others were childhood AV blocks, diagnosed at 2, 7, and 15 years of age. Although one evolved to type I second degree AV block, none of them required cardiac pacing with a mean follow-up of 5.0 + 1.7 years.
The prevalence of narrow QRS complex was significantly higher (P ¼ 0.043) in the presence of complete AV block and escape rhythm (92 children, 92%) than in the presence of incomplete AV block and conducted QRS complex (32 children, 78.0%). The prevalence of narrow QRS complex was also significantly higher (P ¼ 0.004) in the presence of childhood (106 children, 92.2%) than congenital (18 children, 69.2%) AV block. In the 17 patients whose QRS complex was wide, the intraventricular conduction morphology was complete LBBB in 6, left posterior fascicular block in 5 with extreme right axis deviation, complete RBBB in 5, while left alternating with RBBB was observed in 1 infant. At last follow-up of three non-paced children, complete AV block had spontaneously regressed to normal AV conduction in one, and to type I second degree AV block in two patients. No relationship was found between degree of AV block and gender or age at diagnosis, and the evolution of AV block was not related to age at the time of diagnosis or at the time of pacing system implantation. The mean ECG intervals measured at the time of diagnosis and pacemaker implantation are shown in Table 1 .
Age at implantation of the first pacemaker
After a mean follow-up of 11.7 + 0.6 years, 112 patients (79.4%) had received a permanent pacemaker, implanted during the first year of life in 18 (16.1%), and before 10 years of age in 90 (80.4%) children ( Figure 4) . The mean age at pacemaker implant was 32.0 + 69.8 months in case of congenital AV block and was 80.3 + 57.2 in case of childhood AV block. One patient, who was under surveillance for complete AV block since the 22nd week of gestation and presented with hydrops fetalis at 37 weeks, was delivered by caesarean section and underwent permanent cardiac pacing, beginning in the perinatal period. Permanent epicardial pacing beginning at birth or in the neonatal period was required in four additional infants, who presented with heart failure due to profound bradycardia (mean heart rate at birth 63.0 + 9.9 ms).
The mean time interval between diagnosis of congenital AV block and device implantation was 31.8 + 69.9 months (0 -300 months), and 30 + 39.2 months (0-155 months) between diagnosis of childhood AV block and onset of permanent pacing ( Figure 5) . One hundred and nine children were implanted with a delay of more than 6 months between the diagnosis of AV block and the implantation. In these children, the indication of pacemaker implantation was prophylactic in 66 cases (60%).
Types of conduction disturbances at the time of pacemaker implantation
The ECG recorded at the time of pacemaker implantation revealed the presence of complete AV block with narrow QRS complex in 95 of the 112 paced patients (84.8%), including 13 of 26 presenting with congenital (50.0%), and 81 of 115 prevalence of narrow QRS complexes was significantly higher (P ¼ 0.043) in the presence of complete AV block and escape rhythm than in the presence of incomplete AV block and conducted QRS complexes. The prevalence of narrow QRS complexes was also significantly higher (P ¼ 0.004) in the presence of childhood than congenital AV block. Wide QRS complexes were present in 30.8% of patients with congenital AV block. AVB, atrio-ventricular block.
Non-immune heart block in the young presenting with childhood (70.4%) AV block. Complete AV block with a wide QRS complex was observed in 8 (30.8%) patients presenting with congenital AV block and 9 (7.8%) presenting with childhood AV block. At the time of pacemaker implantation, type II 2 nd degree AV block with narrow QRS complex was recorded in a single patient (0.9%) presenting with childhood AV block.
Indications, type, and mode of cardiac pacing
Permanent pacemakers were implanted for symptomatic bradycardia in 42 children (37.5%). Bradycardia-related manifestations included asthenia in 37 (33.3%), exercise-induced dyspnoea in 21 (19.0%), syncope in 16 (14.3%), and chest pain in 5 (4.8%) patients.
In 70 permanently paced children (61.6%), the indications were prophylactic, including a mean daytime heart rate ,50 b.p.m. in 49 (43.7%) children .1 year of age, ventricular pauses longer than 3 RR intervals in 39 (34.8%) children, a heart rate ,50 b.p.m. in 13 (11.6%) infants, a prolonged corrected QT interval in 4 (3.6%) children, and an escape rhythm with wide QRS complex in 3 (2.7%) children. The pacing indications were not related to age at diagnosis. A significantly greater proportion of males (39 children, 55.7%) than females (31 children, 44.3%) were paced for prophylactic indications (P ¼ 0.02).
Among 18 infants who were permanently paced before 1 year of age, epicardial leads were implanted in 15, with a single chamber device in 10 and a dual chamber device in 5. A single infant received a dual chamber device with endocardial leads and two other infants were implanted transvenously with a single chamber device. Among 72 children between the ages of 1 and 10 years, 25 (34.7%) received epicardial and 47 (65.3%) received endocardial leads. Single chamber devices were implanted in 47 (65.3%), and dual chamber pacemaker in 25 (34.7%) children. Among 51 children .10 years of age, 51 (100%) received endocardial leads and 46 (91%) received a dual chamber pacing system.
We divided the study in three period of time. Before 1990, between 1990 and 2000 and after 2000. During the first period 12 children were implanted, the indication for implantation was prophylactic in 10 cases (83%). During the second period 26 children were implanted, the indication for implantation was prophylactic in 15 cases (56%). During the last period 74 children were implanted, the indication for implantation was prophylactic in 45 cases (60%). Even if the indication seems stable over time, the mode of implantation changed as, in the first period, all the children except one were implanted using epicardial leads, in the second period 19 children were implanted using endocardial leads (73%), and finally, in the last period 51 children (69%) were implanted using endocardial leads. On the contrary, during the three period of time, the number of children paced with a 
Clinical outcomes
The follow-up was .5 years in 121 (85.8%), .10 years in 84 (59.6%), and .15 years in 49 (34.8%) children. After a mean follow-up of the entire study population of 11.6 + 6.7 years (range 1-32), no patient had died or developed DCM, and 127 (90.1%) had remained free from AV block-related complication at the last visit. The 100% long-term survival of the 12 patients presenting with sero-negative, isolated foetal AV block, of whom 2 (16.6%) were not paced at last follow-up, is particularly noteworthy. Dilated cardiomyopathy with severe, symptomatic LV systolic dysfunction developed 1 year after the onset of permanent right ventricular apical pacing in a 9-year-old child who presented with childhood complete AV block. Cardiac magnetic resonance imaging showed suggested viral myocarditis. Spontaneous and complete normalization of the LV dimensions and systolic function within 6 months, and normal ECG and general health at 20 months of follow-up, made pacing-induced cardiomyopathy much less likely. Pacemaker-related complications occurred in 13 children (9.2%), ranged in major ones in 7 (4.9%) with pacemaker lead endocarditis in 2, lead rupture in 3, lead dysfunction in 2, and in minor ones in 6 (4.3%) with diaphragmatic or pectoral stimulation in 4, self-limited pericardial effusion in 1, and device dislodgment in 1 patient.
Discussion
While several studies have examined the outcome of foetal and antibody-associated complete AV block, the natural history of paediatric idiopathic AV block is poorly known. Our study is the largest one of isolated non-immune AV block, congenital in 26 patients, and diagnosed later in childhood in 115 patients. Our main observation was a highly favourable long-term prognosis, whatever the age of the patient at the time of diagnosis.
Long-term outcomes
None of the 141 children died or developed irreversible LV dysfunction due to DCM. Isolated, congenital AV block is associated with a high prevalence of maternal antibodies and high mortality, particularly when occurring during gestation. 15 In 29 foetal AV blocks reported by Jaeggi et al., 3 90% was immune-mediated and associated with a 43% long-term mortality. The prognosis of childhood AV block, immune-mediated in 5% of cases, is better. 3, 16 In our study, the long-term prognosis of paediatric isolated, nonimmune AV block was favourable, with permanent pacing implemented as recommended in published, professional practice guidelines. 17 -20 The long-term outcome was not dependent on age, degree of heart block, or on the presence vs. absence of symptoms at the time of diagnosis. The clinical presentation and longterm prognosis of the 26 patients with congenital isolated AV block, vs. the 115 patients diagnosed later in life with isolated childhood AV block, in the absence of maternal antibodies, were similar. Our observations suggest that the prognosis is closely related to the maternal immune status, since the long-term prognosis of children with non-immune disease was favourable, including when it was diagnosed during foetal life.
Progression to complete atrioventricular block
We have previously described that incomplete sero-negative isolated heart block evolve more frequently than the immune ones. 16 Here, in our 42 children whose AV block was incomplete at the time of diagnosis, 70% progressed to complete AV block Non-immune heart block in the young over a mean of ,3 years, regardless of their age at the time of diagnosis. This progression suggests (i) the existence of a post-natal degenerative disorder of the specialized conduction system, and (ii) the need to closely follow the ECG of children presenting with isolated, incomplete AV block.
Paediatric cardiac pacing
The incidence of pacemaker implantation in our cohort is high (79%). These results are in line with the previous publication in this field with an incidence of pacemaker implantation varying from 95 to 66%. 3, 16 We observed a surprisingly low rate of pacemaker-related complications, compared with earlier publications. 3, 21 Over a mean follow-up of nearly 12 years, ,10% of children suffered an even minor pacemaker-related complication.
Our study was retrospective and conducted at multiple medical centres, increasing the likelihood of underestimating the rate of adverse events, despite the exclusion of children with missing follow-up data. However, these observations are consistent with the 3.3% rate of major pacemaker-related complications in children reported by Welisch et al. 22 in their institution, and with other long-term follow-up paediatric pacing experiences. 23 As a result of technological progress and growing experience in the young, paediatric permanent cardiac pacing was safe and effective. Nearly two-third of the permanent pacemakers were implanted for prophylactic indications. Michaelsson et al. 24 had reported a high incidence of unpredictable Stokes-Adams attacks due to isolated congenital AV block, and a high mortality associated with the first attack. In our study, prophylactic pacing, as currently recommended, 17, 19 is associated with strong reduction in the morbidity and mortality due to Stokes-Adams attacks.
Non-immune, isolated atrioventricular block and risk of dilated cardiomyopathy
Dilated cardiomyopathy is one of the major complications of congenital and antibody-associated AV block, associated with a high mortality, 16,25 -29 though no patient in our study developed irreversible DCM. Several trials and studies 29 -33 in patients paced for complete AV block have observed an association between (i) long-term RV apical pacing and (ii) ventricular remodelling and prognosis. Dyssynchronous electro-mechanical activation induced by apical pacing and the reversal of DCM after upgrade of the system to biventricular stimulation support the hypothesis of detrimental effects of RV apical pacing on LV function. However, patients paced at the RV apex do not all develop DCM, suggesting the existence of an individual susceptibility to the detrimental effects of RV apical pacing. 34 Kim et al. reported a 92% rate of cumulative dysfunction free survival at 20 years follow-up in a series of 63 children. Furthermore, in children with normal cardiac anatomy, pacing-induced dyssynchrony may be observed in the absence of degradation of right ventricular systolic function. Dilated cardiomyopathy has been described before pacemaker implantation in children with antibody-associated complete AV block and some authors have proposed that, in seropositive AV block, DCM may be due to myocardial injury caused by an inflammatory process, which may progress or be reactivated. 16, 35, 36 In our study, no child developed DCM, regardless of the diagnostic age and despite a long follow-up and a high prevalence of permanent right ventricular apical pacing. Our results are concordant with those of the recent study by Sagar et al. 37 in adults, suggesting that long-term RV apical pacing alone does not appear to be associated with development of LV systolic dysfunction and heart failure in non-immune isolated AV block.
While developing DCM is unlikely to occur in isolated nonimmune AV block, we recommend close echocardiographic monitoring, including of patients presenting with seronegative complete AV block.
Limitations
The 29 years of data collected for this study represents a limitation, since clinical practice has evolved, and considerable progress has been made in prenatal diagnosis and early cardiac pacing. In addition, since the review of medical records was not exhaustive at all hospitals, the prevalence of this type of AV block may have been underestimated. Incomplete AV blocks and especially lower degrees such as first-degree AV block were underreported in the database, and those who underwent pacemaker placement were more likely to be included in the database, constituting a bias in inclusion. The retrospective data collection at multiple medical centres may also have underestimated the incidence of adverse events during follow-up. Data on siblings or second children were not available.
